Press Releases | NeoGenomics Laboratories

As of November 1, 2020, we will discontinue future development for Internet Explorer

To have a better experience, please upgrade to Microsoft Edge, Google Chrome, or Firefox. Sorry for the convenience.

Presented: February 5, 2021

NeoGenomics Schedules its Fourth Quarter and Full Year 2020 Earnings Release for February 24, 2021

Presented: July 31, 2019

NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore

Presented: July 30, 2019

NeoGenomics Reports 50% Revenue Growth to Record $102 Million in the Second Quarter

Presented: July 9, 2019

NeoGenomics to Build State-of-the-Art Oncology Laboratory and Global Headquarters in Fort Myers, Florida

Presented: July 1, 2019

NeoGenomics Schedules its Second Quarter Earnings Release for July 30, 2019

Presented: June 27, 2019

NeoGenomics Announces New $250 Million Credit Agreement

Presented: May 30, 2019

NeoGenomics To Present At 39th Annual William Blair Growth Stock Conference

Presented: May 28, 2019

NeoGenomics and QIAGEN Collaborate to Offer Companion Diagnostic Test for HR+/HER2 - Advanced Breast Cancer Patients to Detect a PIK3CA Mutation

Presented: May 23, 2019

NeoGenomics To Attend The 16th Annual Craig-Hallum Institutional Investor Conference

Presented: May 21, 2019

NeoGenomics Announces Pricing on Public Offering of Common Stock

Presented: May 20, 2019

NeoGenomics Announces Proposed Public Offering of Common Stock